Diseases, Conditions, Syndromes

Three major scientific controversies about coronavirus

Although political leaders have closed borders in response to COVID-19, scientists are collaborating like never before. But the coronavirus (SARS-COV-2) is novel—and we don't yet have all the facts about it. As a result, ...

Diseases, Conditions, Syndromes

COVID-19: Immune system gone astray

Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction—rather, the immune response is caught in a continuous loop of activation and inhibition. ...

Diseases, Conditions, Syndromes

Drug prevents multiple sclerosis relapses in phase 3 trial

A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common ...

Diseases, Conditions, Syndromes

COVID-19: The virus and the vasculature

The novel coronavirus SARS-CoV-2 infects the respiratory tract and in severe cases, the infection can result in lung failure, which necessitates the use of mechanical ventilation. In addition, these patients develop further ...

Diseases, Conditions, Syndromes

Boosting immune system a potential treatment strategy for COVID-19

As the COVID-19 pandemic continues to claim lives around the world, much research has focused on the immune system's role in patients who become seriously ill. A popular theory has it that the immune system gets so revved ...

Immunology

TLK protein inhibition activates the innate immune system

Tousled-like kinases (TLKs) are a potential therapeutic target for cancer treatment due to their central role in DNA repair and replication. The latest work by IRB Barcelona's Genomic Instability and Cancer Laboratory, led ...

page 3 from 100